Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,000 | 1 | 48.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,750 | 4 | 45.9% |
| Food and Beverage | $591.91 | 26 | 5.7% |
| Education | $14.50 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $5,000 | 1 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,750 | 3 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $2,000 | 1 | $0 (2017) |
| FUJIFILM Healthcare Americas Corporation | $170.47 | 2 | $0 (2022) |
| AbbVie Inc. | $164.55 | 11 | $0 (2023) |
| Janssen Biotech, Inc. | $113.23 | 8 | $0 (2019) |
| Laborie Medical Technologies Corp. | $64.54 | 1 | $0 (2023) |
| Celgene Corporation | $31.94 | 2 | $0 (2023) |
| Amgen Inc. | $29.55 | 1 | $0 (2022) |
| Medtronic, Inc. | $17.63 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $141.28 | 6 | Laborie Medical Technologies Corp. ($64.54) |
| 2022 | $231.84 | 6 | FUJIFILM Healthcare Americas Corporation ($142.97) |
| 2021 | $5,804 | 5 | GlaxoSmithKline, LLC. ($5,000) |
| 2020 | $14.89 | 1 | AbbVie Inc. ($14.89) |
| 2019 | $1,089 | 7 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($1,000) |
| 2018 | $1,056 | 5 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($1,000) |
| 2017 | $2,019 | 2 | Valeant Pharmaceuticals North America LLC ($2,000) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/22/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.08 | General |
| Category: Neuroscience | ||||||
| 09/15/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.86 | General |
| Category: Neuroscience | ||||||
| 09/12/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2023 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $64.54 | General |
| 06/14/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: IMMUNOLOGY | ||||||
| 01/06/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2022 | Amgen Inc. | AVSOLA (Biological) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Inflammation | ||||||
| 09/14/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2022 | FUJIFILM Healthcare Americas Corporation | FUJIFILM (Device) | Food and Beverage | In-kind items and services | $142.97 | General |
| Category: Medical Device | ||||||
| 05/19/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/07/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2022 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Gastrointestinal AI | ||||||
| 09/28/2021 | FUJIFILM Healthcare Americas Corporation | FUJIFILM (Device) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Medical Device | ||||||
| 08/05/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 06/25/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/11/2021 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Gastroenterology | ||||||
| 01/20/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/05/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/15/2019 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Immunology | ||||||
| 04/17/2019 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Immunology | ||||||
| 03/13/2019 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI, REMICADE | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Immunology | ||||||
| 02/25/2019 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Immunology | ||||||
| 02/13/2019 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Immunology | ||||||
| 01/16/2019 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 291 | 349 | $140,239 | $31,811 |
| 2022 | 10 | 573 | 659 | $400,857 | $72,813 |
| 2021 | 9 | 610 | 721 | $418,432 | $79,428 |
| 2020 | 11 | 603 | 703 | $361,903 | $67,230 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 117 | $26,625 | $11,034 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 74 | 103 | $28,325 | $6,469 | 22.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $18,230 | $3,252 | 17.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $24,576 | $3,030 | 12.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,320 | $2,396 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 30 | $5,550 | $2,150 | 38.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 26 | 27 | $26,013 | $2,097 | 8.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $5,600 | $1,383 | 24.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 91 | 91 | $110,032 | $13,199 | 12.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 123 | 174 | $40,830 | $13,017 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 109 | $24,775 | $11,144 | 45.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 46 | 46 | $38,615 | $8,974 | 23.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 83 | 85 | $81,979 | $7,419 | 9.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 29 | 29 | $38,190 | $5,979 | 15.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 43 | 43 | $13,910 | $4,387 | 31.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $23,800 | $3,246 | 13.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 12 | 12 | $10,060 | $2,354 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 19 | $3,520 | $1,317 | 37.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 14 | 16 | $13,516 | $1,297 | 9.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 12 | 12 | $1,630 | $478.76 | 29.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 151 | 219 | $40,515 | $16,705 | 41.2% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 108 | 108 | $130,784 | $14,270 | 10.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 57 | 57 | $43,430 | $11,542 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 108 | $19,790 | $11,051 | 55.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 38 | 39 | $51,540 | $8,637 | 16.8% |
About Dr. Anthony Dimarino, M.D
Dr. Anthony Dimarino, M.D is a Gastroenterology healthcare provider based in Phila, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780643775.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Dimarino, M.D has received a total of $10,356 in payments from pharmaceutical and medical device companies, with $141.28 received in 2023. These payments were reported across 32 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($5,000).
As a Medicare-enrolled provider, Dimarino has provided services to 2,077 Medicare beneficiaries, totaling 2,432 services with total Medicare billing of $251,282. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Phila, PA
- Active Since 03/20/2006
- Last Updated 12/06/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1780643775
Products in Payments
- XIFAXAN (Drug) $4,750
- FUJIFILM (Device) $170.47
- STELARA (Biological) $113.23
- Mavyret (Drug) $36.95
- ZEPOSIA (Drug) $31.94
- RINVOQ (Biological) $30.68
- AVSOLA (Biological) $29.55
- CREON (Drug) $27.74
- SKYRIZI (Biological) $26.06
- GI GENIUS (Device) $17.63
- HUMIRA (Biological) $14.89
- LINZESS (Drug) $14.86
- Kanuma (Drug) $14.50
- VIBERZI (Drug) $13.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Phila
David Loren, M.d, M.D
Gastroenterology — Payments: $155,206
Mitchell Conn, M.d, M.D
Gastroenterology — Payments: $69,572
Thomas Kowalski, M.d, M.D
Gastroenterology — Payments: $68,411
David Kastenberg, M.d, M.D
Gastroenterology — Payments: $49,066
Michael Dimarino, M.d, M.D
Gastroenterology — Payments: $12,257
Cuckoo Choudhary, M.d, M.D
Gastroenterology — Payments: $8,877